GlassScriptPhysician profile
James Harris
NPI 1215632971
$1,403.30
in general payments reported to CMS, 2019-2025
8 companies · $311 in 2025
The $311 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $61.26 · 2024: $1,031 · 2025: $311.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,105 · Travel and Lodging: $299.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,104.80 |
| Travel and Lodging | $298.50 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $810.73 | 2023-2024 | Journey II, Real Intelligence, Journey |
| Sanara Medtech INC. | $145.35 | 2024 | Celleraterx |
| Innovation Technologies INC | $127.53 | 2025 | Irrisept |
| Zimmer Biomet Holdings, INC. | $101.80 | 2025 | Arcos |
| Peerless Surgical INC. | $80.09 | 2024-2025 | |
| Globus Medical, INC. | $51.39 | 2024 | Elsa |
| Stryker Corporation | $47.04 | 2023 | Hoffmann, Axsos |
| Depuy Synthes Sales INC. | $39.37 | 2025 | Trialtis, Vertigraft, Acis |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Harris listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.